2015
DOI: 10.1210/jc.2014-3465
|View full text |Cite
|
Sign up to set email alerts
|

Circulating Fibroblast Growth Factor 21 Levels Predict Progressive Kidney Disease in Subjects With Type 2 Diabetes and Normoalbuminuria

Abstract: Elevated serum FGF21 levels may be a useful biomarker for predicting kidney disease progression, especially in the early stages of diabetic nephropathy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

7
53
1
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 78 publications
(63 citation statements)
references
References 28 publications
(31 reference statements)
7
53
1
1
Order By: Relevance
“…In agreement with other studies (Stein et al, 2009, Zhang et al, 2015, Lee et al, 2015) serum levels of the FGF-21 depend on renal functions because renal elimination is a major route by which physiological FGF-21 serum levels are maintained. Like other researches (Stein et al, 2009, Lee et al, 2015) we found that GFR is significantly and inversely associated with circulating FGF-21 level.…”
Section: Discussionsupporting
confidence: 92%
“…In agreement with other studies (Stein et al, 2009, Zhang et al, 2015, Lee et al, 2015) serum levels of the FGF-21 depend on renal functions because renal elimination is a major route by which physiological FGF-21 serum levels are maintained. Like other researches (Stein et al, 2009, Lee et al, 2015) we found that GFR is significantly and inversely associated with circulating FGF-21 level.…”
Section: Discussionsupporting
confidence: 92%
“…For the log etransformed FGF21 level, HR and OR are expressed per one SD increase in log e -transformed level GFR in the FIELD study [12,17] and other studies [13,26], and be elevated in both chronic and acute renal dysfunction [27]. In a recent study of 1,136 Chinese patients with type 2 diabetes, higher circulating FGF21 levels predicted estimated GFR decline over 4 years, even in a subgroup of 559 patients with normal estimated GFR and normoalbuminuria [28]. Fenofibrate is also known to cause an increase in plasma creatinine [19].…”
Section: Discussionmentioning
confidence: 99%
“…In NAFLD and CKD patients, circulating and tissue FGF21 levels are increased rather than reduced, correlate with disease severity [74,75], and are normalized by therapeutic interventions [76]. Furthermore, elevated circulating FGF21 levels precede and predict the incidence of diabetic nephropathy [77], indicating that FGF21 resistance is an early and possibly causal factor in the development of obesity-related disorders. Mechanisms underlying FGF21 resistance are under investigation, but may include downregulation of FGFR1 and b-Klotho expression [64].…”
Section: The Liver As a Determinant Of Kidney Injurymentioning
confidence: 99%